H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL)

Why is Nvidia’s market cap hitting $4 trillion? How will Trump’s Brazil tariffs impact US prices? What caused Ford’s massive US vehicle recall? Why is Tesla expanding Robotaxi service in Phoenix? How did Delta restore its profit outlook? What’s behind Indeed and Glassdoor job cuts? Why is Amazon considering more investment in Anthropic?

H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL)

finance.yahoo.com/news/h-c-wainwright-reiterates-buy-151412213.html

In This Article:
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 3, H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) and set a price target of $57.00. The…

This story appeared on finance.yahoo.com, 2025-07-10 15:14:12.